Frailty assessment in geriatric radiation oncology.
Frailty
G8
Geriatric assessment
Geriatric screening tool
Radiotherapy
Journal
Advances in cancer research
ISSN: 2162-5557
Titre abrégé: Adv Cancer Res
Pays: United States
ID NLM: 0370416
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
22
9
2024
pubmed:
22
9
2024
entrez:
21
9
2024
Statut:
ppublish
Résumé
Older adults with cancer are at risk of over-treatment or under-treatment, and treatment decision-making is difficult due to both the complexity of adverse aging and under-representation in clinical trials. It is recommended to perform a frailty assessment before treatment decision-making. Although the importance of radiotherapy increases in geriatric oncology, there is less evidence base information on frailty assessment in radiation oncology than in medical/surgical oncology. The present literature review analyzed the available data regarding frailty assessment tools in geriatric radiation oncology. The predictive value of geriatric assessment on survival outcomes has been shown in many cancer subtypes treated with radiotherapy. Additionally, the Geriatric-8 score is the most evidenced screening tool in frailty assessment. However, researches are ongoing on the cut-off points of geriatric screening tools and which one is the best. Prospective randomized controlled trials are required for the integration of geriatric screening tools and geriatric assessment-driven interventions into geriatric radiation oncology practice.
Identifiants
pubmed: 39306368
pii: S0065-230X(24)00069-1
doi: 10.1016/bs.acr.2024.07.003
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
283-309Informations de copyright
Copyright © 2024. Published by Elsevier Inc.